What Is a Fractional Chief Medical Officer? A Complete Guide for Healthcare Founders

If you have searched "fractional chief medical officer" recently, you will have encountered pages of results about Chief Marketing Officers. The role of a fractional Chief Medical Officer is relatively new, often misunderstood, and still largely absent from mainstream search results — which is precisely why it represents such a significant opportunity for the growing number of healthcare organisations that need one.

This guide explains exactly what a fractional Chief Medical Officer is, what they do, when you need one, and how the model works in practice. Whether you are a digital health founder preparing for an NHS procurement bid, a MedTech CEO navigating UKCA marking, or a private clinic group facing a CQC inspection, this is the guide you have been looking for.

The Basic Definition

A fractional Chief Medical Officer is a senior, board-level physician who provides medical and clinical leadership to an organisation on a part-time basis. "Fractional" simply refers to the fraction of their working time they dedicate to your organisation — typically one to two days per week. They work across multiple client organisations simultaneously, bringing the same depth of expertise you would expect from a full-time CMO at a fraction of the cost.

The role should be distinguished from a medical consultant (who delivers a specific, time-limited piece of work), a locum (who provides clinical coverage), and an interim CMO (who works full-time for a temporary period). A fractional CMO is embedded in your leadership team on an ongoing basis, owns clinical workstreams, attends board meetings, and builds institutional knowledge over time.

What Does a Fractional Chief Medical Officer Actually Do?

The scope of a fractional CMO engagement depends on the organisation's needs, but typically spans the following areas:

• Clinical governance: Building and owning the clinical governance framework — policies, procedures, clinical audit, serious incident review, and quality improvement.
• Regulatory affairs: Navigating MHRA, NICE, UKCA/CE marking, and other UK regulatory requirements. Acting as the senior clinical lead in regulatory submissions and inspections.
• Patient safety: Implementing patient safety systems, leading serious incident investigations, and owning the organisation's safety culture.
• Medical affairs: Publications strategy, KOL engagement, clinical evidence generation, and scientific advisory board governance.
• Digital health compliance: Acting as Clinical Safety Officer under DCB0129, leading DTAC assessments, and overseeing clinical AI governance.
• Board and investor representation: Providing credible clinical leadership at board level and in investor meetings, due diligence processes, and fundraising rounds.
• Named Medical Director: Acting as the named Medical Director, Responsible Officer, or Designated Prescribing Practitioner where required by regulators.

Who Needs a Fractional Chief Medical Officer?

The fractional CMO model is designed for organisations that sit in a specific gap: too complex and regulated to operate without senior clinical leadership, but not yet large or well-funded enough to justify a full-time appointment.

That gap is occupied by a significant and growing population of UK organisations:

• Digital health start-ups and scale-ups preparing for NHS procurement or digital health assessments
• MedTech SMEs seeking UKCA or CE marking for their devices
• Early-stage biotech and pharma companies building their first medical affairs function
• Private clinic groups, aesthetic clinics, and care providers regulated by the CQC
• Consumer health brands needing medical affairs and health claims substantiation
• Corporate health and occupational health businesses
• Health insurers and insurtech products with clinical components

The common thread is an organisation operating in a clinically or regulatory-complex environment, with either no in-house clinical leadership or only junior clinical staff, where the CEO or founder is currently carrying clinical governance responsibilities they are not equipped or insured to own.

The Fractional Model vs Full-Time Hire: The Cost Comparison

A full-time Chief Medical Officer at a UK healthcare organisation would typically command £200,000–£350,000 in base salary, plus employer pension contributions, benefits, and potentially a bonus — making the true on-cost £250,000–£450,000 per year, before recruitment fees which typically run to £40,000–£80,000 for a role of this seniority.

A fractional CMO engagement at one to two days per week costs a fraction of this. For most organisations in the £2m–£30m revenue range, the fractional model provides the clinical leadership they need at an investment that is proportionate to their stage. This is not a compromise — it is the right model for the stage.

How Long Does a Fractional CMO Engagement Last?

Good fractional CMO engagements have a minimum of six months. This is not arbitrary. Clinical governance and regulatory work requires sustained attention, institutional knowledge, and trust. A CMO who arrives for two months cannot build the relationships, understand the risks, or deliver the outcomes that a six-month engagement can. The minimum term exists to protect both parties and to ensure every engagement delivers genuine value rather than a paper exercise.

Most engagements run for 12–24 months. Some organisations transition to a permanent appointment once they reach scale; others continue with the fractional model indefinitely because it continues to meet their needs efficiently.

What to Look for in a Fractional CMO

Not all fractional CMOs are created equal. When evaluating candidates or services, look for:

• Full GMC registration with a current licence to practise
• Relevant sector experience (MedTech, digital health, NHS, pharma, as applicable)
• Experience of the specific regulatory frameworks relevant to your organisation
• Previous board-level clinical leadership experience
• A clear, structured approach to onboarding and governance assessment
• Transparent contractual arrangements and clear conflict of interest policies

The Bottom Line

A fractional Chief Medical Officer is not a compromise solution for organisations that cannot afford a full-time hire. For the majority of growing healthcare organisations in the UK, it is the right model — providing genuine board-level clinical leadership at a cost and time commitment that is proportionate to the organisation's stage and needs.

The question is not whether you can access a CMO. The question is whether the fractional model is the right structure for your specific clinical, regulatory, and commercial context. The best way to answer that question is a 30-minute conversation.